Sanofi gets rated buy today ... as it has been driving revenue from multiple products rather than a single magic drug.

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National Medical Products Administration (NMPA), which announced its approval the same day.

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

To combat this, allergy medication Allegra created Allegra Airways, a website designed to help find and map real-time routes ...

For its “Allegra Airways” campaign, the allergy medication brand used real-time pollen and air pollution data to find pockets ...

which align with our commitment to advancing transformative therapies for unmet medical needs.” Julien Dodet President of the Governing Board, Orano Med “Sanofi’s partnership with Orano Med ...

But Sanofi said efforts will focus on difficult-to-treat cancers, both hematological malignancies and solid tumors that have critical unmet medical need, including rare cancers such as multiple ...

and packaging of Sanofi’s SoloStar insulin pens and advanced insulin products. This strategic partnership reinforces our commitment to reduce the burden of importing medicines, increase access to high ...

Approximately $30 million of this current quarter amount is related to commercial and medical affairs related ... economics ...

Global medical companies are launching hundreds of state-of-the-art technologies in the medical product pavilion of the ...

Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...